SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. )
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a12
C4 THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check boxes that apply):
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 011.
C4 Therapeutics, Inc.
Annual Meeting of Stockholders
Wednesday, June 22, 2022
Supplement to Definitive Proxy Statement dated April 29, 2022
On April 29, 2022, C4 Therapeutics, Inc. (the Company) filed a definitive proxy statement (the Proxy Statement) with the Securities and Exchange Commission in connection with the Companys Annual Meeting of Stockholders to be held on June 22, 2022 (the 2022 Annual Meeting). The Company is providing this supplement solely to correct one inadvertent error in the Proxy Statement.
The Notice of 2022 Annual Meeting of Stockholders included in the Proxy Statement incorrectly stated that our 2022 Annual Meeting will be held on Tuesday, June 22, 2022 at 8:30 am Eastern Time. In fact, June 22, 2022 is a Wednesday and, as such, the meeting will be held on Wednesday, June 22, 2022 at 8:30 am Eastern Time.
Except as described above, this supplement to the Proxy Statement does not modify, amend, supplement, or otherwise affect the Proxy Statement. If you have already voted, you do not need to vote again unless you would like to change or revoke your prior vote on any proposal. If you would like to change or revoke your prior vote on any proposal, please refer to the Proxy Statement for instructions on how to do so.